Assessment of industry data on pulmonary and immunosuppressive effects of IQOS

Tobacco Control

Volumn 27, Issue , 2018, Pages s20-s25

  Moazed, Farzad ^a   Chun, Lauren ^b   Matthay, Michael A ^a   Calfee, Carolyn S ^a   Gotts, Jeffrey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

non cigarette tobacco products; tobacco industry; toxicology

Indexed keywords

ADULT; AEROSOL; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LUNG; MALE; PHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; STATISTICS AND NUMERICAL DATA; TOBACCO; TOBACCO INDUSTRY; YOUNG ADULT;

ADULT; AEROSOLS; ANIMALS; FEMALE; HUMANS; IMMUNOSUPPRESSION; INFLAMMATION; LUNG; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RATS; TOBACCO INDUSTRY; TOBACCO PRODUCTS; YOUNG ADULT;

EID: 85052957928     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2018-054296     Document Type: Article

References (23)

1. Finkelstein R, Fraser RS, Ghezzo H, et al. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 1995;152(Pt 1):1666-72.
2. Walser T, Cui X, Yanagawa J, et al. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc 2008;5:811-5.
3. Takahashi H, Ogata H, Nishigaki R, et al. Tobacco smoke promotes lung tumorigenesis by triggering IKKbeta- and JNK1-dependent inflammation. Cancer Cell 2010;17:89-97.
4. Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004;164:2206-16.
5. Almirall J, Bolíbar I, Balanzó X, et al. Risk factors for community-acquired pneumonia in adults: A population-based case-control study. Eur Respir J 1999;13:349-55.
6. Almirall J, Bolíbar I, Serra-Prat M, et al. New evidence of risk factors for communityacquired pneumonia: A population-based study. Eur Respir J 2008;31:1274-84.
7. Almirall J, González CA, Balanzó X, et al. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. Chest 1999;116:375-9.
8. Top 10 causes of death worldwide. WHO Fact Sheet, 2017.
9. Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thorac Soc 2014;11:404-6.
10. World Health Organization. WHO global report on trends in tobacco smoking 2000- 2025, 2015.
11. Wong ET, Kogel U, Veljkovic E, et al. Evaluation of the Tobacco Heating System 2. 2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke. Regul Toxicol Pharmacol 2016;81(Suppl 2):S59-S81.
12. Aspinall R, Andrew D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 2000;18:1629-37.
13. Berard M, Tough DF. Qualitative differences between naïve and memory T cells. Immunology 2002;106:127-38.
14. Hunninghake GW, Gadek JE, Kawanami O, et al. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979;97:149-206.
15. Pavord ID, Pizzichini MM, Pizzichini E, et al. The use of induced sputum to investigate airway inflammation. Thorax 1997;52:498-501.
16. Scanlon PD, Connett JE, Waller LA, et al. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med 2000;161(Pt 1):381-90.
17. Pride NB. Smoking cessation: effects on symptoms, spirometry and future trends in COPD. Thorax 2001;56(Suppl 2):ii7-10.
18. van der Plas LP SD, Dobrynina M, Baker G, et al. Prevalence and patterns of tobacco use in Japan after the commercialization of a heat-not-burn alternative (IQOS) to cigarettes. 2017. www. pmiscience. com
19. Tabuchi T, Gallus S, Shinozaki T, et al. Heat-not-burn tobacco product use in Japan: its prevalence, predictors and perceived symptoms from exposure to secondhand heatnot- burn tobacco aerosol. Tob Control 2018;27:e25-e33.
20. O'Connell GWP, Burseg KMM, Stotesbury SJ, et al. Heated tobacco products create side-stream emissions: implications for regulation. Journal of Environmental Analytical Chemistry 2015;163:2380-91.
21. Auer R, Concha-Lozano N, Jacot-Sadowski I, et al. Heat-Not-Burn tobacco cigarettes: smoke by any other name. JAMA Intern Med 2017;177:1050-2.
22. Protano C, Manigrasso M, Avino P, et al. Second-hand smoke generated by combustion and electronic smoking devices used in real scenarios: Ultrafine particle pollution and agerelated dose assessment. Environ Int 2017;107:190-5.
23. World Health Organization. WHO report on the global tobacco epidemic, 2009.